4.4 Article

Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention

Journal

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
Volume 13, Issue 7, Pages 971-978

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/18715206113139990119

Keywords

Akt; mTOR; apigenin; cancer

Funding

  1. NIH [CA161181, CA104768]
  2. American Cancer Society, Illinois Division, Inc. [167567]
  3. Zell Foundation
  4. Rosenberg Fund
  5. H Foundation
  6. Northwestern University Skin Disease Research Center
  7. Cell Imaging Facility
  8. Robert H. Lurie Comprehensive Cancer Center

Ask authors/readers for more resources

Natural products are important sources of anti-cancer lead molecules, and high dietary consumption of fruits and vegetables is associated with a reduced risk of certain cancers. Many efforts have been devoted to identifying and developing plant-derived dietary constituents as chemopreventive agents. Among them, apigenin, a naturally occurring flavonoid found in a variety of fruits and leafy vegetables, has been shown to possess remarkable anti-oxidant, anti-inflammatory and anti-carcinogenic properties. This review summarizes the anti-cancer and chemopreventive effects of apigenin at cellular and molecular levels, its chemical structure and properties, with focus on mechanism related to apigenin's inhibition of the PI3K/Akt/mTOR signaling pathways.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available